CNTA - Centessa Pharmaceuticals plc
12.01
-1.560 -12.989%
Share volume: 1,051,567
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$13.57
-1.56
-0.12%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-13-2024 | 08-14-2023 | 11-13-2023 | 11-12-2024 | 05-13-2024 | 08-13-2024 | 11-12-2024 | 03-24-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 6.853 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 6.853 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | inf% | -100.00% | nan% | nan% | nan% | |||
| Operating expenses | 48.877 M | 47.019 M | 40.209 M | 42.031 M | 36.090 M | 43.980 M | 46.405 M | 74.580 M | |
| Selling general and admin | 16.051 M | 13.346 M | 12.019 M | 12.315 M | 13.438 M | 11.165 M | 12.502 M | 13.706 M | |
| Research and development | 32.826 M | 33.673 M | 28.190 M | 29.716 M | 22.652 M | 32.815 M | 33.903 M | 60.874 M | |
| Total expenses | 48.877 M | 47.019 M | 40.209 M | 42.031 M | 36.090 M | 43.980 M | 46.405 M | 74.580 M | |
| -3.80% | -14.48% | 4.53% | -14.13% | 21.86% | 5.51% | 60.72% | |||
| Operating income | -48.877 M | -47.019 M | -40.209 M | -35.178 M | -36.090 M | -43.980 M | -46.405 M | -74.580 M | |
| Ebit | -50.223 M | -48.546 M | -41.886 M | -36.056 M | -37.627 M | -43.826 M | -42.741 M | -78.548 M | |
| Pretax income | -50.037 M | -48.937 M | -41.474 M | -35.693 M | -37.565 M | -43.111 M | -41.958 M | -110.279 M | |
| -2.20% | -15.25% | -13.94% | 5.24% | 14.76% | -2.67% | 162.83% | |||
| Income tax | 677.000 K | -24.051 M | -2.826 M | 1.144 M | 481.000 K | 705.000 K | 608.000 K | 1.050 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -50.714 M | -24.886 M | -38.648 M | -36.837 M | -38.046 M | -43.816 M | -42.566 M | -111.329 M | |
| 50.93% | -55.30% | 4.69% | -3.28% | -15.17% | 2.85% | -161.54% |
